Ever Source Wealth Advisors, LLC Nuvalent, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 179 shares of NUVL stock, worth $17,536. This represents 0.0% of its overall portfolio holdings.
Number of Shares
179
Previous 49
265.31%
Holding current value
$17,536
Previous $3,000
333.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NUVL
# of Institutions
227Shares Held
59.8MCall Options Held
191KPut Options Held
306K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.76 Billion31.57% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.27MShares$516 Million18.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$443 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$296 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.8MShares$176 Million0.02% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $4.21B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...